Fig. 3
From: The impact of tau-PET in a selected memory clinic cohort: rationale and design of the TAP-TAU study
Example PET scans of a visually negative (A), moderately positive (B) and advanced positive (C) tau-PET scan determined following the FDA approved visual read method for [18F]flortaucipir. The scans are from study participants at the Amsterdam University Medical Center who participated in previous tau-PET studies